| abstract |
The present invention provides antibodies (particularly monoclonal antibodies), chimeric antibodies, humanized antibodies and human antibodies that specifically recognize human alpha 9 integrin; Hybridoma cells producing said monoclonal antibody; A method for producing said monoclonal antibody; A method for producing the hybridoma cell; A therapeutic agent containing said anti-human alpha 9 integrin antibody; A diagnostic agent containing the human alpha 9 integrin antibody; A method for screening a compound that inhibits the activity of human alpha 9 integrin, and the like. |